REVXF 주가 차트
REVXF 수입
Revenio Group Oyj
$16.41
0%
$0
종가: Jun 22, 16:00:00 GMT-4
$16.41
0%
$0
프리마켓: Jun 23, 09:17:21 GMT-4
뒤로
Revenio Group Oyj (REVXF) 수입
최신 수익 결과: Q1 '26
보고됨: 2026-04-28
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
REVXF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Revenio Group Oyj REVXF의 지난 분기 매출 실적은 어땠나요?
Revenio Group Oyj의 매출 추정치는 얼마인가요?
Revenio Group Oyj의 수익 품질 점수는 얼마인가요?
Revenio Group Oyj는 언제 수익을 보고하나요?
Revenio Group Oyj의 예상 수익은 얼마인가요?
Revenio Group Oyj은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$16.41
시가
$16.41
일일 범위
$16.41 - $16.41
52주 범위
$16.41 - $31.47
거래량
1.0K
평균 거래량
31
배당수익률
--
EPS(TTM)
0.68
시가총액
$477.3M
REVENIO GROUP OYJ란 무엇인가요?
Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 246 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
